Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum must be delayed in Africa (multiple letters)

Trends in Parasitology

Volumn 18, Issue 7, 2002, Pages 293-294

  Rieckmann, Karl ^a   Cheng, Qin ^a   Watkins, William M ^b   Winstanley, Peter A ^b   Sibley, Carol Hopkins ^c  

^a AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOQUINOLINE; AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CHLORPROGUANIL; DAPSONE; FANSIDAR; MEFLOQUINE;

AFRICA; ALLELE; DRUG COST; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; HUMAN; LETTER; MALARIA; MALARIA FALCIPARUM; PARASITE DEVELOPMENT; PARASITE SURVIVAL; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

AFRICA; AMODIAQUINE; ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SESQUITERPENES; SULFADOXINE;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 0036629979     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4922(02)02287-0     Document Type: Letter

References (10)

1. Sibley C.H., et al. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 17:2001;582-588.
2. Wilairatana P., et al. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria. Ann. Trop. Med. Parasitol. 91:1997;125-132.
3. Rieckmann K., et al. Response of Plasmodium falciparum infections to pyrimethamine-sulfadoxine in Thailand. Am. J. Trop. Med. Hyg. 37:1987;211-216.
4. Wilairatana P., et al. A clinical trial of combination of artesunate and mefloquine in the treatment of acute uncomplicated falciparum malaria: a short and practical regimen. Southeast Asian J. Trop. Med. Public Health. 29:1998;696-701.
5. Van Dillen J., et al. A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya. Trans. R. Soc. Trop. Med. Hyg. 93:1999;185-188.
6. Brasseur P., et al. Amodiaquine remains effective for treating uncomplicated malaria in West and Central Africa. Trans. R. Soc. Trop. Med. Hyg. 93:1999;645-650.
7. Sowunmi A., et al. Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated Plasmodium falciparum malaria in children. Ann. Trop. Med. Parasitol. 95:2001;549-558.
8. Rieckmann K.H. Determination of the drug sensitivity of Plasmodium falciparum. J. Am. Med. Assoc. 217:1971;573-578.
9. Staedke S.G. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet. 358:2001;368-374.
10. Doberstyn E.B. Treatment of vivax malaria with sulfadoxine- pyrimethamine and with pyrimethamine alone. Trans. R. Soc. Trop. Med. Hyg. 73:1979;15-17.